Citadel Advisors’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Hold
412,531
﹤0.01% 3093
2025
Q1
$1.76M Sell
412,531
-615,003
-60% -$2.62M ﹤0.01% 2715
2024
Q4
$5.43M Buy
1,027,534
+347,023
+51% +$1.83M ﹤0.01% 1732
2024
Q3
$1.25M Buy
680,511
+15,139
+2% +$27.7K ﹤0.01% 2907
2024
Q2
$1.38M Buy
665,372
+639,424
+2,464% +$1.33M ﹤0.01% 2759
2024
Q1
$104K Sell
25,948
-12,087
-32% -$48.5K ﹤0.01% 5066
2023
Q4
$71.1K Buy
38,035
+15,892
+72% +$29.7K ﹤0.01% 4990
2023
Q3
$37K Buy
22,143
+12,135
+121% +$20.3K ﹤0.01% 5174
2023
Q2
$23.9K Sell
10,008
-36,179
-78% -$86.5K ﹤0.01% 5208
2023
Q1
$143K Buy
46,187
+31,339
+211% +$97.2K ﹤0.01% 4767
2022
Q4
$39.8K Sell
14,848
-155,674
-91% -$417K ﹤0.01% 5354
2022
Q3
$505K Sell
170,522
-72,049
-30% -$213K ﹤0.01% 4070
2022
Q2
$711K Sell
242,571
-163,677
-40% -$480K ﹤0.01% 3773
2022
Q1
$2.08M Sell
406,248
-22,118
-5% -$113K ﹤0.01% 2972
2021
Q4
$2.89M Buy
428,366
+81,935
+24% +$553K ﹤0.01% 2655
2021
Q3
$2.4M Buy
346,431
+4,410
+1% +$30.5K ﹤0.01% 2796
2021
Q2
$3.33M Buy
342,021
+100,507
+42% +$979K ﹤0.01% 2629
2021
Q1
$3.8M Buy
+241,514
New +$3.8M ﹤0.01% 2434
2020
Q1
Sell
-1,174
Closed -$19K 5292
2019
Q4
$19K Buy
+1,174
New +$19K ﹤0.01% 4514
2019
Q3
Sell
-1,051
Closed -$17K 5121
2019
Q2
$17K Buy
+1,051
New +$17K ﹤0.01% 4513
2018
Q2
Sell
-452
Closed -$45K 4569
2018
Q1
$45K Buy
+452
New +$45K ﹤0.01% 3761
2017
Q2
Sell
-312
Closed -$22K 4152
2017
Q1
$22K Buy
+312
New +$22K ﹤0.01% 3511